Table 3

Incidence of uncomplicated falciparum malaria and anemia stratified for hemoglobin genotypes

β-Globin genotypeMalaria
Anemia
EventsPYARRate (per year)IRR (95%CI)EventsPYARRate (per year)IRR (95% CI)
HbAA 1327 1108.7 1.2 787 1217.7 0.6 
HbAC 193 149.1 1.3 1.08 (0.93-1.26)* 121 163.2 0.7 1.15 (0.95-1.39) 
HbCC 3.4 0.0 — 3.4 0.9 1.38 (0.44-4.28) 
HbAS 153 164.3 0.9 0.78 (0.66-0.92) 59 179.7 0.3 0.51 (0.39-0.66) 
HbCS 16.4 0.4 0.36 (0.17-0.75)§ 18 17.3 1.0 1.61 (1.01-2.57) 
HbSS 7.6 0.5 0.44 (0.17-1.18) 40 7.0 5.7 8.84 (6.43-12.1) 
β-Globin genotypeMalaria
Anemia
EventsPYARRate (per year)IRR (95%CI)EventsPYARRate (per year)IRR (95% CI)
HbAA 1327 1108.7 1.2 787 1217.7 0.6 
HbAC 193 149.1 1.3 1.08 (0.93-1.26)* 121 163.2 0.7 1.15 (0.95-1.39) 
HbCC 3.4 0.0 — 3.4 0.9 1.38 (0.44-4.28) 
HbAS 153 164.3 0.9 0.78 (0.66-0.92) 59 179.7 0.3 0.51 (0.39-0.66) 
HbCS 16.4 0.4 0.36 (0.17-0.75)§ 18 17.3 1.0 1.61 (1.01-2.57) 
HbSS 7.6 0.5 0.44 (0.17-1.18) 40 7.0 5.7 8.84 (6.43-12.1) 

PYAR indicates person-years at risk; and —, not applicable.

*

Trend of an agonistic epistatic effect by α+-thalassemia toward susceptibility: IRR HbAC plus αα/αα = 0.98; 95% CI, 0.82-1.18; IRR HbAC plus α/αα = 1.43; 95% CI, 1.11-1.84.

P < .005 (Poisson regression). Relative risk estimate significantly different from that of HbAC (test of interaction, z = 2.83, P < .005). Trend of an antagonistic epistatic effect by α+-thalassemia against protection: IRR HbAS plus αα/αα = 0.76; 95% CI, 0.63-0.93; IRR HbAS plus α/αα = 0.82, CI 0.58-1.16.

P < .001 (Poisson regression). Relative risk estimate significantly different from that of HbAC (test of interaction, z = 4.91, P < .001).

§

P < .01 (Poisson regression).

P < .001 (Poisson regression).

Close Modal

or Create an Account

Close Modal
Close Modal